{"name":"VectivBio AG","slug":"vectivbio-ag","ticker":"","exchange":"","domain":"","description":"VectivBio AG is a clinical-stage biotechnology company focused on the development of innovative therapies for patients with significant unmet medical needs. The company's lead candidate, apraglutide, is in Phase 3 development for the treatment of short bowel syndrome (SBS).","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Apraglutide","genericName":"Apraglutide","slug":"apraglutide","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Apraglutide","genericName":"Apraglutide","slug":"apraglutide","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQYU1yYjBOYm9Cay04NDl4Smhqa1gydUhlNC1oUzctMEY3bTNuaERxMzNuc1k2TldxS1lCSTRNazFuM3BKeV9ZWlJzdEFRaEFiNUNWMXRkTzMzaWo0Wm5EbXJDekIwaUxDdTFLYjRWNVd3WFJPUWZXOUQtNU9yUmp5TVY2MXhCcW9Vb3BuelI4Q0pDUFV5YzZRYlZNMEVLVVd6WHZJMUtESWVCWll5alFRYjZ1WFdJNjJLSURrSVRNQTNNd0VPSE9reDlOMUc?oc=5","date":"2025-12-23","type":"deal","source":"Investing.com","summary":"Ironwood Pharmaceuticals amends license deal with Ferring, settles litigation - Investing.com","headline":"Ironwood Pharmaceuticals amends license deal with Ferring, settles litigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNMnBYbi02YXg0OEFpTDFac3ZkSlk0WldPWjNLWTNXUk5udXlBZlNBMG50VWV6eTJibUhHdWNjRnUxN21TU1pNQmh4Rjlic29Tc3c2YXVqOTA2UHlpMFlVX0ZaNVIwVnRIOGhxbnpfTUlWSnhUQy1jdlN1b2RCYkI3RlR6QkVXVTBCRUgyam1ZOGw?oc=5","date":"2025-12-23","type":"pipeline","source":"The Business Journals","summary":"Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property - The Business Journals","headline":"Boston biotech settles lawsuit alleging misappropriation of GLP-2 analog intellectual property","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQaXFkb05VTnEzM1JSUEx0VGt1eHNnTTJNUW5oSmdJVVluNVI0SS1xdWhNTlhvX2lJWnBRc1NWRUlsRUpRb2J3X1FzLUFRb01MQWw1LU9kLVBKaGdYb0pTd2tsVjRnTTg0Z1U2cUxCTlNISWRXTG9tN0NoOFVSTmJKbjNDenU3bzM2Vmc?oc=5","date":"2025-11-11","type":"deal","source":"The Business Journals","summary":"Biotech acquired by Ironwood faces allegations of misappropriating trade secrets - The Business Journals","headline":"Biotech acquired by Ironwood faces allegations of misappropriating trade secrets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNbElNVW4wREl5dkR5bC1fTHNDZGFqUmJPY1lrZ3VPeXc5bUVKOVhSRko4UmlFUXIxTm1mWWZtbWJSY0hjNkF0aGo2M0VfSnBtNnBCd3pCTzAwOHZjY1BhN0RjOWowVkI2UWZYRHhhN0s5R2VnMThWa2U2Q2sxdTVhYUlOUUV2dTdnTS0td251dGdGVzh4YUlkVTNydVRVN2lMNFBycHN1dW9EWlFu0gG0AUFVX3lxTFBtemFNR2htZkdFWkhDUWU1TF9TMjYwWnQxeXU5NnRsZldHeW5sWTdfRi1fZTV6aTFHbU9wNjg4MHg5bWpUOVNFMTM1WjE5Zm9RMzFtWjRVbzZYZGNqMFdnblVGemxnS2tTU2s4NzZLOTJhMTdlYWJNOS13ZTFHak5FUUkwMlUwckpMdThMcXo2ZXE1aGdZNEhjbElkQm9UQVEyNVBxbjdhRHQxWWl2TWVISUdRRA?oc=5","date":"2025-11-11","type":"pipeline","source":"NBC Boston","summary":"Boston-based drug developer hit with IP complaint - NBC Boston","headline":"Boston-based drug developer hit with IP complaint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNWlIyX0JzN3lIMmJLNkprcXpRQ05vV3ctdy1KZTNrdUEtakJTU21LcU1nUklFZWh2QnBoaGxWRUhiNDBQTHZERzM4eHBiWXZNTFhIYmxnaUlzeldwYTl6SW10QWFpamx5VFM2STZIc09SdkZCQW4wRHNCOUEwX2xNVXp0d29GbFhmNlhYbExuLUJZU2Fhb3VhSU9tWGhULUpzQlphQS1Uc05VdkpZTUd2dDF1RjZmTFVNalU2RTAyRWJxXzRzTDRCSG04a1VuNmNhV0xudUhnNVIzLWUzeDhrTGZZc0M4U2dSdHU2S013X0tMQThZYXQtb0NSMHdVdkVBYTlZ?oc=5","date":"2023-06-16","type":"patent","source":"Business Wire","summary":"Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio - Business Wire","headline":"Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPTjZvVW5XcTRpSDhFb216TUNqWXR1UWZwYTlGTWE1QTdwWVBqekM2QjNOTGxvb0hjVk81d0RpZ2V0dUJVQy1NZGVsX2ZxMFNiNm96M0xlb0pYZllMbTY3MlFoT1piaHd6YjRBNEs3aHI1VFVZdHRPUm5ZdzFMNnczaVpmekNuWmVGWjNlQ1FPdnQ?oc=5","date":"2023-05-24","type":"pipeline","source":"European Biotechnology Magazine","summary":"VectivBio taken over in $1bn acquisition - European Biotechnology Magazine","headline":"VectivBio taken over in $1bn acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOeGlQd1RmV2JibWRTUjRER1dkdGRIdDNaREpnRW4xdmVMRG1zOWZkVlZqQTFuSDhxZ2NrV0ZGOUtRNHpLVFNzUnQ2dkRXTm9sT1FKc2M0UTIyaUQ5WWFBaGZtUHotZzhNWktwR3VuYmFEUjk4UkNES3lzLTJibXRRZzZCcVp5OHpaclh1dk5oVmlMVWNySFRHcHowNTJTX1Q1empR?oc=5","date":"2023-05-23","type":"deal","source":"Startupticker.ch","summary":"Ironwood Pharma to acquire VectivBio for more than USD 1 billion - Startupticker.ch","headline":"Ironwood Pharma to acquire VectivBio for more than USD 1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE52SzY3U2IxNUVpTGMxNUxWM2VoX1VNQ3pPSXFiTU0yYklvVG45SC1Cc0dfS3d1QjlHNGZJZ1hDWVdlNEUwSXJQcGlPQTFKM1NXTkZEVnNKRFNzOFZpa082eTIteGxLUXVEdGVCbUFUaGhoZG8?oc=5","date":"2023-05-23","type":"deal","source":"Labiotech.eu","summary":"Ironwood acquires VectivBio in $1B deal - Labiotech.eu","headline":"Ironwood acquires VectivBio in $1B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxNdVIwRUQteEVSOHhtWnFSWkhDVUtyNUE5TDJ6ajlETGY3aUdYNnhwNHhxUEVFdWxOOV9KeUo1c3RQVlRPWnBTMU5LelprOU5XN0FlOWdNd0pSMHFqRWVaTC1ZYlZKOUtRZm84MVhmaWV5bUFOT2NZUlctQ0E3bEJxMDhsbkF1TVVvdnVKODFUdGtacmRpcEhFU3Jxa3RsdXlUaUdJY2RGTUY5QVJmOWh5ZGE5UktXWEY4VG9BdlFYcjhlTWdPRHdFTUJTS2tkTlJ5Q0tBdGhETzEtRUU2T25TZUVGUW9SOERlekpVRHR2V05HUTJNWWdGUDM1aFB2TXFfeDVOczkweUxuejRfOEs4VHBOTUs0MUJmRGNqZlQ2Vzl6cDcwOW5ZVXQtcG05RzZ3TEtrX1RTNGYxRm5QZEV2U0k0bFk?oc=5","date":"2023-05-22","type":"deal","source":"Business Wire","summary":"Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases - Business Wire","headline":"Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQTl6QnY5TV9QX1VJUk5LVU9aNk1ra1MxYnd3VzZuUTB5VllfOHZWM3FYc2loQjd5aTgtOWlBMUtBWTZiRUw2WTBwbWRncXpLRFQ3dlB2WF9ZTDFVaG5rQi1NNURZNVFremQ3LWEycW9Ta052WjJ1ZDF2alhCN3VUUEdfRGVaUG5Dc2hIdnphQ1o0RE1paGIxMWo1aWRmOWxxbnNNSDBVN21YUQ?oc=5","date":"2023-05-22","type":"deal","source":"reuters.com","summary":"Ironwood bulks up on digestive therapies with $1.15 bln VectivBio buy - reuters.com","headline":"Ironwood bulks up on digestive therapies with $1.15 bln VectivBio buy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}